Challenges and opportunities in managing pregnant patients with abnormal cervical cytology and positive HPV result in Poland: a single-center retrospective analysis
Folia Medica Cracoviensia · 2025
DOI: 10.24425/fmc.2025.156128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Medica Cracoviensia, 2025. Verfasst von Dominika Trojnarska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal and Child Health, Institute of Nursing and Midwifery, Faculty of Health Sciences, Jagiellonian University Medical College, Kra…. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms, Pregnancy Complications, Neoplastic, Uterine Cervical Dysplasia.
Abstract (Originalsprache)
Objectives
The study examined the natural progression of squamous intraepithelial lesions (SIL) and human papilloma virus (HPV) infection during pregnancy, comparing initial and postpartum results. It also assessed delivery mode’s impact on outcomes and strategies to improve follow-up care for women with abnormal cervical cancer screening results.
Methods
This retrospective study analyzed data from 59 pregnant women with SIL/positive HPV, assessing variables such as cytology, HPV status, and delivery mode. Statistical tests included Wilcoxon rank-sum and Fisher’s exact tests.
Results
The average age of patients was 29 years. Over 50% were primigravidas. A significant reduction in abnormal cytology was observed postpartum (89.83% vs. 62.50%, p = 0.009), with an increase in normal results (10.17% vs. 37.50%). No significant differences were found in HPV status (88.89% vs. 81.25%, p = 0.655). Colposcopy findings were stable for 76.32% of patients between Visits 1 and 2, with 50% stability between Visits 2 and 3. Postpartum, 30.43% showed regression, while 8.70% showed progression (p = 0.017, padj >0.050). Higher regression rates were observed after vaginal birth compared to the cesarean section (45.45% vs. 15.38%, p = 0.182) but no significant differences were found (p = 1.000). Almost 60% of patients were lost to postpartum follow-up.
Conclusion
Further studies with a larger population of Polish patients are needed. Cervical cancer screening should be optimized and integrated into a national registry. Pregnant patients with abnormal screening results should be managed by experts, and strategies to enhance patient compliance must be implemented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Maternal and Child Health, Institute of Nursing and Midwifery, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków; Clinical Department of Gynecological Endocrinology and Gynecologi…
- Clinical Department of Gynecological Endocrinology and Gynecological Oncology,University Hospital in Kraków, Poland.
- Clinical Department of Gynecological Endocrinology and Gynecological Oncology, University Hospital in Kraków, Poland.
- Clinical Department of Gynecological Endocrinology and Gynecological Oncology, University Hospital in Kraków; Chair of Gynecology and Obstetrics, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Pol…
Zitieren
APA
Trojnarska, D., Wielgus, M., Górnisiewicz, K., Kot, J., & Jach, R. (2025). Challenges and opportunities in managing pregnant patients with abnormal cervical cytology and positive HPV result in Poland: a single-center retrospective analysis. Folia Medica Cracoviensia. https://doi.org/10.24425/fmc.2025.156128
Vancouver
Trojnarska D, Wielgus M, Górnisiewicz K, Kot J, Jach R. Challenges and opportunities in managing pregnant patients with abnormal cervical cytology and positive HPV result in Poland: a single-center retrospective analysis. Folia Medica Cracoviensia. 2025. doi:10.24425/fmc.2025.156128
BibTeX
@article{Trojnarska2025,
author = {Trojnarska, Dominika and Wielgus, Marzenia and Górnisiewicz, Krzysztof and Kot, Justyna and Jach, Robert},
title = {Challenges and opportunities in managing pregnant patients with abnormal cervical cytology and positive HPV result in Poland: a single-center retrospective analysis},
journal = {Folia Medica Cracoviensia},
year = {2025},
doi = {10.24425/fmc.2025.156128}
}
EUVIMED